Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Protease activated receptor 2 controls myelin development, resiliency and repair.

Glia | 2017

Oligodendrocytes are essential regulators of axonal energy homeostasis and electrical conduction and emerging target cells for restoration of neurological function. Here we investigate the role of protease activated receptor 2 (PAR2), a unique protease activated G protein-coupled receptor, in myelin development and repair using the spinal cord as a model. Results demonstrate that genetic deletion of PAR2 accelerates myelin production, including higher proteolipid protein (PLP) levels in the spinal cord at birth and higher levels of myelin basic protein and thickened myelin sheaths in adulthood. Enhancements in spinal cord myelin with PAR2 loss-of-function were accompanied by increased numbers of Olig2- and CC1-positive oligodendrocytes, as well as in levels of cyclic adenosine monophosphate (cAMP), and extracellular signal related kinase 1/2 (ERK1/2) signaling. Parallel promyelinating effects were observed after blocking PAR2 expression in purified oligodendrocyte cultures, whereas inhibiting adenylate cyclase reversed these effects. Conversely, PAR2 activation reduced PLP expression and this effect was prevented by brain derived neurotrophic factor (BDNF), a promyelinating growth factor that signals through cAMP. PAR2 knockout mice also showed improved myelin resiliency after traumatic spinal cord injury and an accelerated pattern of myelin regeneration after focal demyelination. These findings suggest that PAR2 is an important controller of myelin production and regeneration, both in the developing and adult spinal cord.

Pubmed ID: 28921694 RIS Download

Associated grants

  • Agency: NINDS NIH HHS, United States
    Id: R01 NS052741

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Novus Biologicals (tool)

RRID:SCR_004286

Commercial antibody vendor which supplies antibodies and other products to life science researchers.

View all literature mentions

PeproTech (tool)

RRID:SCR_006802

An Antibody supplier

View all literature mentions

Phospho-Akt (Ser473) (193H12) Rabbit mAb (antibody)

RRID:AB_331168

This monoclonal targets Phospho-Akt (Ser473) (193H12) Rabbit mAb

View all literature mentions

Myelin PLP antibody (antibody)

RRID:AB_776593

This polyclonal targets Myelin PLP antibody

View all literature mentions

PAR-2 (C-17) (antibody)

RRID:AB_2101309

This polyclonal targets F2RL1

View all literature mentions

C57BL/6J (organism)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions

B6.Cg-F2rl1tm1Mslb/J (organism)

RRID:IMSR_JAX:004993

Mus musculus with name B6.Cg-F2rl1tm1Mslb/J from IMSR.

View all literature mentions

C57BL/6J (organism)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions

B6.Cg-F2rl1tm1Mslb/J (organism)

RRID:IMSR_JAX:004993

Mus musculus with name B6.Cg-F2rl1tm1Mslb/J from IMSR.

View all literature mentions

Myelin PLP antibody (antibody)

RRID:AB_776593

This polyclonal targets Myelin PLP antibody

View all literature mentions

PAR-2 (C-17) (antibody)

RRID:AB_2101309

This polyclonal targets F2RL1

View all literature mentions

Phospho-Akt (Ser473) (193H12) Rabbit mAb (antibody)

RRID:AB_331168

This monoclonal targets Phospho-Akt (Ser473) (193H12) Rabbit mAb

View all literature mentions